Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Patrys Ltd (PAB.AX)

Patrys Ltd (PAB.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Patrys Ltd 385 Bourke Street Suite 2, Level 11 Melbourne VIC 3000 AUS

P: +61 396703273

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Patrys Ltd is a biopharmaceutical company focused on developing novel antibody-based therapies prominently for cancer and related inflammatory diseases. Its core technology platform involves antibodies that penetrate cell nuclei and inhibit cancer cell DNA repair mechanisms. The company advances therapeutic candidates from its antibody platforms, including ones licensed from Yale University, with ongoing preclinical and clinical development activities. Patrys generates revenue through licensing agreements and collaborations linked to its antibody technologies. Its operations and development efforts span Australia and the United States.

Key Statistics

Overview:

Market Capitalization, $K 8,862
Shares Outstanding, K 4,583,757
% of Institutional Shareholders 0.09%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -3,013 K

Growth:

1-Year Return -13.33%
3-Year Return -90.37%
5-Year Return -90.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 0.00
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 10/13/25

PAB.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -143.39%
Return-on-Assets % -102.13%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 12.09
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar